The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma

Lianhua Zhu, Eunae Cho, Guohua Zhao, MiRyung Roh, Zhenlong Zheng

Research output: Contribution to journalArticle

Abstract

Background/Aim: Cortactin (CTTN) has been considered a promising molecular prognostic factor in various types of cancers. In this study, we aimed to investigate the role of CTTN in the pathogenesis of cutaneous squamous cell carcinoma (CSCC). Materials and Methods: CTTN and phospho-CTTN (p-CTTN) expression was determined in 10 healthy controls and 38 CSCC tissue samples by immunohistochemistry. The influence of CTTN on the biological behavior of CSCC cells was also investigated. Results: p-CTTN expression was significantly increased in CSCC than control samples. In contrast, no significant difference in CTTN expression was found between control and CSCC tissues. Moreover, a significant association was found between recurrence-free survival with p-CTTN expression, but not with CTTN expression. Furthermore, the proliferative, migratory, and invasive abilities of CSCC cells were significantly decreased by CTTN-siRNA transfection. Conclusion: CTTN phosphorylation is strongly associated with CSCC pathogenesis and may serve as a molecular biomarker of CSCC.

Original languageEnglish
Pages (from-to)393-400
Number of pages8
JournalIn Vivo
Volume33
Issue number2
DOIs
Publication statusPublished - 2019 Mar 1

Fingerprint

Cortactin
Phosphorylation
Tyrosine
Squamous Cell Carcinoma
Skin
Tissue
Epithelial Cells
Biomarkers
Small Interfering RNA
Transfection
Immunohistochemistry
Association reactions

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Zhu, Lianhua ; Cho, Eunae ; Zhao, Guohua ; Roh, MiRyung ; Zheng, Zhenlong. / The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma. In: In Vivo. 2019 ; Vol. 33, No. 2. pp. 393-400.
@article{e2ae76b2fa01476a888b657ef910c1be,
title = "The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma",
abstract = "Background/Aim: Cortactin (CTTN) has been considered a promising molecular prognostic factor in various types of cancers. In this study, we aimed to investigate the role of CTTN in the pathogenesis of cutaneous squamous cell carcinoma (CSCC). Materials and Methods: CTTN and phospho-CTTN (p-CTTN) expression was determined in 10 healthy controls and 38 CSCC tissue samples by immunohistochemistry. The influence of CTTN on the biological behavior of CSCC cells was also investigated. Results: p-CTTN expression was significantly increased in CSCC than control samples. In contrast, no significant difference in CTTN expression was found between control and CSCC tissues. Moreover, a significant association was found between recurrence-free survival with p-CTTN expression, but not with CTTN expression. Furthermore, the proliferative, migratory, and invasive abilities of CSCC cells were significantly decreased by CTTN-siRNA transfection. Conclusion: CTTN phosphorylation is strongly associated with CSCC pathogenesis and may serve as a molecular biomarker of CSCC.",
author = "Lianhua Zhu and Eunae Cho and Guohua Zhao and MiRyung Roh and Zhenlong Zheng",
year = "2019",
month = "3",
day = "1",
doi = "10.21873/invivo.11486",
language = "English",
volume = "33",
pages = "393--400",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "2",

}

The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma. / Zhu, Lianhua; Cho, Eunae; Zhao, Guohua; Roh, MiRyung; Zheng, Zhenlong.

In: In Vivo, Vol. 33, No. 2, 01.03.2019, p. 393-400.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma

AU - Zhu, Lianhua

AU - Cho, Eunae

AU - Zhao, Guohua

AU - Roh, MiRyung

AU - Zheng, Zhenlong

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background/Aim: Cortactin (CTTN) has been considered a promising molecular prognostic factor in various types of cancers. In this study, we aimed to investigate the role of CTTN in the pathogenesis of cutaneous squamous cell carcinoma (CSCC). Materials and Methods: CTTN and phospho-CTTN (p-CTTN) expression was determined in 10 healthy controls and 38 CSCC tissue samples by immunohistochemistry. The influence of CTTN on the biological behavior of CSCC cells was also investigated. Results: p-CTTN expression was significantly increased in CSCC than control samples. In contrast, no significant difference in CTTN expression was found between control and CSCC tissues. Moreover, a significant association was found between recurrence-free survival with p-CTTN expression, but not with CTTN expression. Furthermore, the proliferative, migratory, and invasive abilities of CSCC cells were significantly decreased by CTTN-siRNA transfection. Conclusion: CTTN phosphorylation is strongly associated with CSCC pathogenesis and may serve as a molecular biomarker of CSCC.

AB - Background/Aim: Cortactin (CTTN) has been considered a promising molecular prognostic factor in various types of cancers. In this study, we aimed to investigate the role of CTTN in the pathogenesis of cutaneous squamous cell carcinoma (CSCC). Materials and Methods: CTTN and phospho-CTTN (p-CTTN) expression was determined in 10 healthy controls and 38 CSCC tissue samples by immunohistochemistry. The influence of CTTN on the biological behavior of CSCC cells was also investigated. Results: p-CTTN expression was significantly increased in CSCC than control samples. In contrast, no significant difference in CTTN expression was found between control and CSCC tissues. Moreover, a significant association was found between recurrence-free survival with p-CTTN expression, but not with CTTN expression. Furthermore, the proliferative, migratory, and invasive abilities of CSCC cells were significantly decreased by CTTN-siRNA transfection. Conclusion: CTTN phosphorylation is strongly associated with CSCC pathogenesis and may serve as a molecular biomarker of CSCC.

UR - http://www.scopus.com/inward/record.url?scp=85062172977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062172977&partnerID=8YFLogxK

U2 - 10.21873/invivo.11486

DO - 10.21873/invivo.11486

M3 - Article

VL - 33

SP - 393

EP - 400

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 2

ER -